Literature DB >> 22419695

Developmental expression of renal organic anion transporters in rat kidney and its effect on renal secretion of phenolsulfonphthalein.

Maki Nomura1, Hideyuki Motohashi, Hiroko Sekine, Toshiya Katsura, Ken-ichi Inui.   

Abstract

Organic anion transporters (OAT1 and OAT3) and multidrug resistance-associated proteins (MRP2 and MRP4) play important roles in anionic drug secretion in renal proximal tubules. Changes in the expression of such transporters are considered to affect the tubular secretion of anionic drugs. The purpose of this study was to elucidate the developmental changes in the expression of OAT1, OAT3, MRP2, and MRP4 and their effects on the tubular secretion of drugs. The mRNA level of each transporter was measured by real-time PCR, and the protein expression was evaluated by Western blotting and immunohistochemical analysis. In addition, the tubular secretion of phenolsulfonphthalein (PSP) in infant (postnatal day 14) and adult rats was estimated based on in vivo clearance study. The protein expression of organic anion transporters were very low at postnatal day 0 and gradually increased with age. In postnatal day 14 rats, the expression of OAT1 and OAT3 seemed to be at almost mature levels, while MRP2 and MRP4 seemed to be at immature levels. Immunohistochemical analysis in the kidney of postnatal day 0 rats revealed OATs on the basolateral membrane and MRPs on the brush-border membrane. At postnatal day 0, the distribution of these transporters was restricted to the inner cortical region, while after postnatal day 14, it was identical to that in adult kidney. An in vivo clearance study revealed that the tubular secretion of PSP was significantly lower in postnatal day 14 rats than adult rats. These results indicate that age-dependent changes in organic anion transporter expression affect the tubular secretion of anionic drugs in pediatric patients.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22419695     DOI: 10.1152/ajprenal.00525.2011

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  7 in total

1.  Optimized Renal Transporter Quantification by Using Aquaporin 1 and Aquaporin 2 as Anatomical Markers: Application in Characterizing the Ontogeny of Renal Transporters and Its Correlation with Hepatic Transporters in Paired Human Samples.

Authors:  Cindy Yanfei Li; Chelsea Hosey-Cojocari; Abdul Basit; Jashvant D Unadkat; J Steven Leeder; Bhagwat Prasad
Journal:  AAPS J       Date:  2019-07-11       Impact factor: 4.009

2.  Pharmacokinetics and pharmacogenomics of β-lactam-induced neutropenia.

Authors:  Andrea Hahn; Tsuyoshi Fukuda; David Hahn; Tomoyuki Mizuno; Robert W Frenck; Alexander A Vinks
Journal:  Pharmacogenomics       Date:  2016-04-05       Impact factor: 2.533

Review 3.  Renal Drug Transporters and Drug Interactions.

Authors:  Anton Ivanyuk; Françoise Livio; Jérôme Biollaz; Thierry Buclin
Journal:  Clin Pharmacokinet       Date:  2017-08       Impact factor: 6.447

4.  Organic anion and cation SLC22 "drug" transporter (Oat1, Oat3, and Oct1) regulation during development and maturation of the kidney proximal tubule.

Authors:  Thomas F Gallegos; Gleb Martovetsky; Valentina Kouznetsova; Kevin T Bush; Sanjay K Nigam
Journal:  PLoS One       Date:  2012-07-13       Impact factor: 3.240

Review 5.  Role of solute carriers in response to anticancer drugs.

Authors:  Qing Li; Yan Shu
Journal:  Mol Cell Ther       Date:  2014-05-27

6.  Metabolism and disposition of oseltamivir (OS) in rats, determined by immunohistochemistry with monospecific antibody for OS or its active metabolite oseltamivir carboxylate (OC): A possibility of transporters dividing the drugs' excretion into the bile and kidney.

Authors:  Kunio Fujiwara; Yutaro Yamamoto; Tetsuya Saita; Senya Matsufuji
Journal:  Pharmacol Res Perspect       Date:  2020-06

7.  Transporter-mediated interaction of indican and methotrexate in rats.

Authors:  Shiuan-Pey Lin; Chung-Ping Yu; Yu-Chi Hou; Ching-Ya Huang; Lu-Ching Ho; Shu-Ling Chan
Journal:  J Food Drug Anal       Date:  2017-12-14       Impact factor: 6.157

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.